Huober, J., Holmes, E., Baselga, J., de Azambuja, E., Untch, M., Fumagalli, D., Sarp, S., Lang, I., Smith, I., Boyle, F., Xu, B., Lecocq, C., Wildiers, H., Jouannaud, C., Hackman, J., Dasappa, L., Ciruelos, E., Toral Pena, J. C., Adamchuk, H., Hickish, T., de la Pena, L., Jackisch, C., Gelber, R. D., Piccart-Gebhart, M., & Di Cosimo, S. (2019). survival outcomes of the NeoALTTO study (BIG 1–06): updated results of a randomised multicenter phase III neoadjuvant clinical trial in patients with HER2-positive primary breast cancer. European journal of cancer, 118, 169–177. http://access.bl.uk/ark:/81055/vdc_100089409230.0x000022